glp 1 needle patches Boston biotech secures Series A funding to move its once-weekly GLP-1 obesity patch into first-in-human clinical trials. ㅤ Link in bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech LBMLBM GLP-1 Slimming and health

Safety concerns or gaps in trial data could delay this decision

However, tirzepatide seems to be at least as potent as GLP-1 RAs at lowering blood sugar in those with diabetes

doi:10.1038/s41586-026-10330-z 24.Bezin J, Bnard-Laribire A, Hucteau E, et al

Warning signs to watch for include severe abdominal pain that radiates to the back, nausea that feels different from the usual GI side effects, and fever

Clinical trials have shown that most of these are mild to moderate and decrease with proper dosing adjustments

The tradeoff is variability in product formulation and the fact that compounded GLP-1s are not FDA-approved brand products